BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16839413)

  • 21. [Value of cancer-related oncoprotein expression as prognostic factors in breast-cancer with one to three axillary lymph nodes positive].
    Zhang G; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():66-74. PubMed ID: 8702314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic importance of p53 and c-erbB-2 oncoproteins overexpression in patients with breast cancer.
    Chariyalertsak S; Chariyalertsak S; Cheirsilpa A; Chindavijak K
    J Med Assoc Thai; 1998 Sep; 81(9):698-704. PubMed ID: 9737128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
    BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
    Tan P; Cady B; Wanner M; Worland P; Cukor B; Magi-Galluzzi C; Lavin P; Draetta G; Pagano M; Loda M
    Cancer Res; 1997 Apr; 57(7):1259-63. PubMed ID: 9102210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
    Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma.
    Tsutsui S; Inoue H; Yasuda K; Suzuki K; Tahara K; Higashi H; Era S; Mori M
    Cancer; 2005 Nov; 104(10):2048-53. PubMed ID: 16208702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implication of p53 protein expression in relation to nuclear pleomorphism and the MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Higashi H; Tahara K; Sugita S; Eguchi H; Kayashima H; Miyazaki N; Muto Y; Era S
    Breast Cancer; 2004; 11(2):160-8. PubMed ID: 15550862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of proliferation by Bcl-2 family members.
    Bonnefoy-Berard N; Aouacheria A; Verschelde C; Quemeneur L; Marçais A; Marvel J
    Biochim Biophys Acta; 2004 Mar; 1644(2-3):159-68. PubMed ID: 14996500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA aneuploidy in relation to the combination of analysis of estrogen receptor, progesterone receptor, p53 protein and epidermal growth factor receptor in 498 breast cancers.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    Oncology; 2002; 63(1):48-55. PubMed ID: 12187071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of c-erbB2 expression in breast cancer.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    J Surg Oncol; 2002 Apr; 79(4):216-23. PubMed ID: 11920778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic breast cancer with HER2/neu-positive cells tends to have a morbid prognosis.
    Emi Y; Kitamura K; Shikada Y; Kakeji Y; Takahashi I; Tsutsui S
    Surgery; 2002 Jan; 131(1 Suppl):S217-21. PubMed ID: 11821814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cell-cycle regulator p27 is correlated to the prognosis and ER expression in breast carcinoma patients.
    Nohara T; Ryo T; Iwamoto S; Gon G; Tanigawa N
    Oncology; 2001; 60(1):94-100. PubMed ID: 11150915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of p27Kip1 expression is a strong independent prognostic factor of reduced survival in N0 gastric carcinomas.
    Sgambato A; Migaldi M; Leocata P; Ventura L; Criscuolo M; Di Giacomo C; Capelli G; Cittadini A; De Gaetani C
    Cancer; 2000 Dec; 89(11):2247-57. PubMed ID: 11147595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low levels of cell cycle inhibitor p27kip1 combined with high levels of Ki-67 predict shortened disease-free survival in T1 and T2 invasive breast carcinomas.
    Lau R; Grimson R; Sansome C; Tornos C; Moll UM
    Int J Oncol; 2001 Jan; 18(1):17-23. PubMed ID: 11115534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low expression of bcl-2 in Brca1-associated breast cancers.
    Freneaux P; Stoppa-Lyonnet D; Mouret E; Kambouchner M; Nicolas A; Zafrani B; Vincent-Salomon A; Fourquet A; Magdelenat H; Sastre-Garau X
    Br J Cancer; 2000 Nov; 83(10):1318-22. PubMed ID: 11044356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation.
    Vairo G; Soos TJ; Upton TM; Zalvide J; DeCaprio JA; Ewen ME; Koff A; Adams JM
    Mol Cell Biol; 2000 Jul; 20(13):4745-53. PubMed ID: 10848600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.